159 related articles for article (PubMed ID: 36697230)
1. Reduced Number of Thymoma CTLA4-Positive Cells Is Associated With a Higher Probability of Developing Myasthenia Gravis.
Álvarez-Velasco R; Dols-Icardo O; El Bounasri S; López-Vilaró L; Trujillo JC; Reyes-Leiva D; Suárez-Calvet X; Cortés-Vicente E; Illa I; Gallardo E
Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36697230
[TBL] [Abstract][Full Text] [Related]
2. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
3. Thymoma in Patient with Myasthenia Gravis Has Significantly Fewer Forkhead Box P3 Positive Lymphocytes than that without One.
Nishi T; Yokoyama S; Takamori S; Matsuo T; Murakami D; Akagi Y; Ohshima K
Kurume Med J; 2015; 61(3-4):65-71. PubMed ID: 26460311
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z
PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519
[TBL] [Abstract][Full Text] [Related]
5. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.
Chuang WY; Ströbel P; Gold R; Nix W; Schalke B; Kiefer R; Opitz A; Klinker E; Müller-Hermelink HK; Marx A
Ann Neurol; 2005 Oct; 58(4):644-8. PubMed ID: 16178018
[TBL] [Abstract][Full Text] [Related]
6. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
7. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.
Lefeuvre CM; Payet CA; Fayet OM; Maillard S; Truffault F; Bondet V; Duffy D; de Montpreville V; Ghigna MR; Fadel E; Mansuet-Lupo A; Alifano M; Validire P; Gossot D; Behin A; Eymard B; Berrih-Aknin S; Le Panse R
J Autoimmun; 2020 Jan; 106():102337. PubMed ID: 31594658
[TBL] [Abstract][Full Text] [Related]
9. Thymoma pathology and myasthenia gravis outcomes.
Menon D; Katzberg H; Barnett C; Pal P; Bezjak A; Keshavjee S; Bril V
Muscle Nerve; 2021 Jun; 63(6):868-873. PubMed ID: 33675078
[TBL] [Abstract][Full Text] [Related]
10. Thymectomy and systemic lupus erythematosus (SLE).
Panarese A; D'Andrea V; Pironi D; Filippini A
Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
[TBL] [Abstract][Full Text] [Related]
11. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma.
Zhang M; Zhou Y; Guo J; Li H; Tian F; Gong L; Wang X; Lan M; Li Z; Zhang W
Exp Neurol; 2014 Apr; 254():200-5. PubMed ID: 24518487
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
13. PTPN22 and CTLA-4 gene polymorphisms in resected thymomas and thymus for myasthenia gravis.
Zheng K; Zhang J; Zhang P; Guo Y
Thorac Cancer; 2012 Nov; 3(4):307-312. PubMed ID: 28920273
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of Ctla-4 to myasthenia gravis with thymoma.
Huang D; Liu L; Norén K; Xia SQ; Trifunovic J; Pirskanen R; Lefvert AK
J Neuroimmunol; 1998 Aug; 88(1-2):192-8. PubMed ID: 9688341
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors.
Fujii Y; Okumura M; Yamamoto S
J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845
[TBL] [Abstract][Full Text] [Related]
16. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and outcome of myasthenia gravis with and without thymoma after operation].
Wang RW; Jiang YG; Xue ZQ; Zhao YP; Ma Z
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):536-9. PubMed ID: 15196366
[TBL] [Abstract][Full Text] [Related]
18. Altered naive CD4
Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A
J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
Zhang Y; Yu L; Jing Y; Ke J
Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide association study of myasthenia gravis.
Renton AE; Pliner HA; Provenzano C; Evoli A; Ricciardi R; Nalls MA; Marangi G; Abramzon Y; Arepalli S; Chong S; Hernandez DG; Johnson JO; Bartoccioni E; Scuderi F; Maestri M; Gibbs JR; Errichiello E; Chiò A; Restagno G; Sabatelli M; Macek M; Scholz SW; Corse A; Chaudhry V; Benatar M; Barohn RJ; McVey A; Pasnoor M; Dimachkie MM; Rowin J; Kissel J; Freimer M; Kaminski HJ; Sanders DB; Lipscomb B; Massey JM; Chopra M; Howard JF; Koopman WJ; Nicolle MW; Pascuzzi RM; Pestronk A; Wulf C; Florence J; Blackmore D; Soloway A; Siddiqi Z; Muppidi S; Wolfe G; Richman D; Mezei MM; Jiwa T; Oger J; Drachman DB; Traynor BJ
JAMA Neurol; 2015 Apr; 72(4):396-404. PubMed ID: 25643325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
